Recurrent Breast Cancer Terminated Phase 1 Trials for Alvocidib (DB03496)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00039455Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast CancerTreatment